Detalles de la búsqueda
1.
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation.
Br J Haematol
; 203(5): 840-851, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37614192
2.
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Am J Hematol
; 98(1): 79-89, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251406
3.
Adenovirus Viral Kinetics and Mortality in Ex Vivo T Cell-Depleted Hematopoietic Cell Transplant Recipients With Adenovirus Infection From a Single Center.
J Infect Dis
; 222(7): 1180-1187, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32374872
4.
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(2): 323-332, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31618690
5.
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1526-1535, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30831208
6.
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(6): 1136-1141, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625387
7.
Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations.
Br J Haematol
; 184(6): 1006-1010, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30537212
8.
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience.
Transpl Infect Dis
; 21(6): e13187, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31585500
9.
Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.
Biol Blood Marrow Transplant
; 24(5): 1057-1062, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29287807
10.
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(12): 2517-2522, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30055353
11.
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 24(10): 2017-2024, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29933073
12.
Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(1): 142-149, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28951193
13.
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(1): 133-141, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28870777
14.
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1079-1087, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29325829
15.
CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome .
Biol Blood Marrow Transplant
; 24(5): 964-972, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29305194
16.
Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients.
Transpl Infect Dis
; 20(6): e12977, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120866
17.
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies.
Biol Blood Marrow Transplant
; 23(10): 1685-1694, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28734876
18.
Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia.
Biol Blood Marrow Transplant
; 23(11): 1879-1886, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28694182
19.
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.
Biol Blood Marrow Transplant
; 23(12): 2088-2095, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28711727
20.
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 23(1): 67-74, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27789361